- Exchange: Berlin
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Biotech
Acorda Therapeutics Inc
+ Add to WatchlistCDG:GR
25.305 EUR 0.125 0.50%As of 09:36:19 ET on 06/18/2013.
Snapshot for Acorda Therapeutics Inc (CDG)
| Open: | 25.385 | Day's Range: | 25.305 - 25.385 | Volume: | 0 |
|---|---|---|---|---|---|
| Previous Close: | 25.180 | 52wk Range: | 17.175 - 30.870 | 1-Yr Rtn: | +35.79% |
Key Statistics for CDG
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(12/2013) | 78.8280 |
| Relative P/E vs. DAX | - |
| Earnings Per Share (USD) (ttm) | - |
| Est. EPS (USD) (12/2013) | 0.4300 |
| Est. PEG Ratio | 2.8153 |
| Market Cap (M EUR) | 0.00 |
| Shares Outstanding (M) | 0.00 |
| 30 Day Average Volume | 0 |
| Price/Book (mrq) | - |
| Price/Sale (ttm) | - |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 07/31/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for CDG
Company Profile & Key Executives for CDG
Acorda Therapeutics Inc. is a biotechnology company that is developing therapies for spinal cord injury and related neurological conditions, including multiple sclerosis. Additionally, Acorda is developing multiple approaches to regeneration and repair of the spinal cord and brain.
| Ron CohenPresident/CEO/Founder | David LawrenceChief Financial Officer |
| Enrique J CarrazanaChief Medical Officer | Andrew R Blight "Andy"Chief Scientific Officer |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
CDG News
-
Industry News
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page